2024-11-15T13:27:04-06:00 2023-12-31 231406493 MORISON COGEN LLP 484 NORRISTOWN RD STE 100 BLUE BELL PA 19422 990 2023-01-01 232818395 NATIONAL COMPREHENSIVE CANCER NETWORK NATI 2156900300 3025 CHEMICAL ROAD 100 PLYMOUTH MEETING PA 19462 EILEEN BOSCIA CHIEF FINANCAL OFFICER 2156900300 2024-10-25 1 0 JOSEPH M KISTNER CPA P00157086 2674403000 2023 2024-10-15 13:58:12Z CRYSTAL S DENLINGER MD 3025 CHEMICAL ROAD 100 PLYMOUTH MEETING PA 19462 53802849 0 X WWW.NCCN.ORG X 1993 DE NCCN IS DEDICATED TO IMPROVING AND FACILITATING QUALITY, EFFECTIVE, EQUITABLE, AND ACCESSIBLE CANCER CARE SO ALL PATIENTS CAN LIVE BETTER LIVES. 35 35 179 1912 167815 86229 20368490 19382123 25922116 27438034 1791586 3911937 3982615 3070755 52064807 53802849 1875382 2278263 0 0 24176446 25290359 0 0 654389 9975697 12343413 36027525 39912035 16037282 13890814 133378564 152900973 38753139 37302818 94625425 115598155 X NCCN IS DEDICATED TO IMPROVING AND FACILITATING QUALITY, EFFECTIVE, EQUITABLE, AND ACCESSIBLE CANCER CARE SO ALL PATIENTS CAN LIVE BETTER LIVES. 0 0 19004551 24492460 NCCN GUIDELINES, NCCN CONTENT & EDUCATIONAL PROGRAMS:WITH EXPERTS FROM MAJOR ACADEMIC CANCER CENTERS, DEVELOP AND UPDATE CLINICAL PRACTICE GUIDELINES FOR TREATMENT OF CANCER; INCLUDES BOTH DISTRIBUTION OF GUIDELINES FOR NON-COMMERCIAL USE AS WELL AS CERTAIN EDUCATIONAL CONFERENCES AND SYMPOSIA TO COMMUNICATE CONTENT FREE OF CHARGE. 4819271 2411384 PATIENT INFORMATION:DISSEMINATION OF PATIENT INFORMATION BASED ON GUIDELINES; DEVELOPMENT AND DISSEMINATION OF MEASURES TO ASSESS THE QUALITY OF CARE. 4237306 702005 DEVELOPMENT OF OTHER PUBLIC AND PROFESSIONAL INFORMATION PROGRAMS TO FACILITATE ACCESS TO CANCER SPECIALTY SERVICES. 4049327 2278263 ONCOLOGY RESEARCH:DEVELOPMENT OF A CLINICAL RESEARCH NETWORK OF PHYSICIANS AT MEMBER ACADEMIC CANCER CENTERS TO FACILITATE THE CONDUCT OF STUDIES TO ADVANCE STATE-OF-THE-ART CANCER CARE. 4049327 2278263 32110455 1 1 0 1 0 0 0 0 0 0 1 0 0 1 1 0 1 0 0 0 1 0 0 0 0 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 1 0 0 1 283 0 1 179 1 1 1 0 0 0 0 0 0 0 1 0 X 35 35 0 0 0 0 0 0 0 1 1 0 0 0 1 1 1 1 1 1 1 0 AL AK AZ AR CA CO CT FL GA HI IL KS KY LA ME MD MA MI MS MN MO NH NJ NM NY NC ND OH OK OR PA RI SC TN UT VA WA WV WI X EILEEN BOSCIA 2156900300 3025 CHEMICAL ROAD SUITE 100 PLYMOUTH MEETING PA 19462 JOHN W SWEETENHAM MD FACP FASCO DIRECTOR, CHAIR 2.00 X 0 0 0 MATT KALAYCIO MD DIRECTOR, VICE-CHAIR 2.00 X 0 0 0 THEODOROS TEKNOS MD DIRECTOR 2.00 X 0 0 0 ASHLEY B LEE DIRECTOR 2.00 X 0 0 0 REBECCA L CAIRES MBA DIRECTOR 2.00 X 0 0 0 PATRICK J O'BRIEN MBA DIRECTOR, TREASURER 2.00 X 0 0 0 DAVID B MILLER MBA DIRECTOR 2.00 X 0 0 0 ROBERT H VONDERHEIDE MD DPHIL DIRECTOR 2.00 X 0 0 0 ELIZABETH A SOUZA MHA DIRECTOR 2.00 X 0 0 0 ROBIN FAMIGLIETTI PHD MBA FACHE DIRECTOR 2.00 X 0 0 0 RAVI SALGIA MD PHD DIRECTOR 2.00 X 0 0 0 CRAIG A BUNNELL MD MBA MPH DIRECTOR 2.00 X 0 0 0 EDWIN P ALYEA III MD DIRECTOR 2.00 X 0 0 0 KYLE F SKIERMONT PHARMD DIRECTOR 2.00 X 0 0 0 BRITTANY MCCREERY MD MBA DIRECTOR 2.00 X 0 0 0 KELVIN P LEE MD DIRECTOR 2.00 X 0 0 0 KENNETH H COWAN MD PHD DIRECTOR 2.00 X 0 0 0 NANCY E DAVIDSON MD DIRECTOR 2.00 X 0 0 0 KATIE MCGILL MSM DIRECTOR 2.00 X 0 0 0 PHILIPPE E SPIESS MD MS FACS FRC DIRECTOR 2.00 X 0 0 0 YVETTE TREMONTI CPA MBA DIRECTOR 2.00 X 0 0 0 GENA COOK DIRECTOR 2.00 X 0 0 0 JORDAN M DEMOSS MSHA DIRECTOR 2.00 X 0 0 0 DAVID SHIBATA MD FACS FASCRS DIRECTOR 2.00 X 0 0 0 TIMOTHY R DONAHUE MD DIRECTOR 2.00 X 0 0 0 DAVID G PFISTER MD DIRECTOR 2.00 X 0 0 0 DAVID C SMITH MD DIRECTOR 2.00 X 0 0 0 PETER CONNOR MS DIRECTOR 2.00 X 0 0 0 KYLE A TAYLOR MHSA CPHQ DIRECTOR 2.00 X 0 0 0 LISLE M NABELL MD DIRECTOR 2.00 X 0 0 0 AL B BENSON III MD FACP FASCO DIRECTOR 2.00 X 0 0 0 STEPHEN B EDGE MD FACS FASCO DIRECTOR 2.00 X 0 0 0 MICHAEL R KUETTEL MD PHD MBA DIRECTOR 2.00 X 0 0 0 TIMOTHY J EBERLEIN MD DIRECTOR 2.00 X 0 0 0 CHRISTINA J LONGNECKER BSN MBA JD DIRECTOR 2.00 X 0 0 0 ALBERTO S PAPPO MD DIRECTOR 2.00 X 0 0 0 WILLIAM E CARSON III MD DIRECTOR 2.00 X 0 0 0 KRIS M KIPP MSN RN DIRECTOR 2.00 X 0 0 0 JAMES E BACHMAN MPA DIRECTOR 2.00 X 0 0 0 DAVID S ETTINGER MD FACP FCCP DIRECTOR 2.00 X 0 0 0 MITCHELL C POSNER MD FACS DIRECTOR 2.00 X 0 0 0 LAUREN WALL MS DIRECTOR 2.00 X 0 0 0 RONALD S WALTERS MD MBA MHA MS DIRECTOR 2.00 X 0 0 0 DAVID T COOKE MD FACS DIRECTOR 2.00 X 0 0 0 GINA DAYTON MPA DIRECTOR 2.00 X 0 0 0 JOSEPH A CALIFANO III MD DIRECTOR 2.00 X 0 0 0 AYAD HAMDAN MD DIRECTOR 2.00 X 0 0 0 BARBARA A JAGELS RN MHA CPHQ DIRECTOR 2.00 X 0 0 0 LAUREL BRAY-HANIN MA DIRECTOR 2.00 X 0 0 0 ALAN P VENOOK MD DIRECTOR 2.00 X 0 0 0 CHRISTOPHER H LIEU MD DIRECTOR 2.00 X 0 0 0 SAMUEL M SILVER MD PHD MACP DIRECTOR 2.00 X 0 0 0 LAURA W GOFF MD MMHC MSCI DIRECTOR 2.00 X 0 0 0 ELIZABETH R PLIMACK MD MS DIRECTOR 2.00 X 0 0 0 SACHIN M APTE MD MBA MS DIRECTOR 2.00 X 0 0 0 DONALD F MILLIGAN MBA DIRECTOR 2.00 X 0 0 0 RONDEEP BRAR MD DIRECTOR 2.00 X 0 0 0 MARIA M GONZALEZ MPH BS DIRECTOR 2.00 X 0 0 0 THERESA SBERNA MPH DIRECTOR 2.00 X 0 0 0 RICHARD D SCHULICK MD MBA FACS DIRECTOR 2.00 X 0 0 0 LEE G WILKE MD FACS DIRECTOR 2.00 X 0 0 0 STEVEN J FRANK MD DIRECTOR 2.00 X 0 0 0 ROBERT R MCWILLIAMS MD MSC DIRECTOR 2.00 X 0 0 0 JOLENE SUMMER BOLSTER DIRECTOR 2.00 X 0 0 0 CYNTHIA MCCOLLUM MBA DIRECTOR 2.00 X 0 0 0 LORI C PICKENS MHA DIRECTOR 2.00 X 0 0 0 ROBERT W CARLSON MD CHIEF EXECUTIVE OFFICER - FORMER 40.00 2.00 X 1140944 0 61847 GARY WEYHMULLER CHIEF OPERATING OFFICER 40.00 2.00 X 603455 0 64470 WUI-JIN KOH MD CHIEF MEDICAL OFFICER 40.00 X 591913 0 47978 CRYSTAL DENLINGER CHIEF EXECUTIVE OFFICER 40.00 2.00 X 479004 0 47978 EILEEN BOSCIA CHIEF FINANCIAL OFFICER 40.00 2.00 X 345361 0 47465 KRISTINA M GREGORY SENIOR VP, CLINICAL INFORMATION P 40.00 X 353057 0 47558 DONNA POWELL MANAGER, RADIATION THERAPY & IMAGING PROGRAMS 40.00 X 189760 0 43111 BETH GAFFNEY VP - US & GLOBAL BUSINESS 40.00 2.00 X 270436 0 70029 JENNIFER TREDWELL SENIOR VP, MARKETING & COMMUNICATIONS 40.00 2.00 X 228174 0 60046 JOSEPH JUNOD SENIOR DIRECTOR, IT 40.00 X 194135 0 51063 EVELYN HANDEL SENIOR DIRECTOR, DRUGS & BIOLOGICS PROGRAMS 40.00 X 195432 0 27807 4591671 0 569352 75 0 1 0 CLINICAL CARE OPTIONS LLC 12001 SUNRISE VALLEY DRIVE SUITE 3 RESTON VA 20191 MEDICAL EDUCATION PROGRAM SERVICES 1561263 MORGAN LEWIS & BOCKIUS LLP PO BOX 8500 S-6050 PHILADELPHIA PA 19178 LEGAL SERVICES 485513 RAM PRODUCTIONS LLC 677 FIFTH STREET ATCO NJ 08004 PROFESSIONAL SERVICES 405010 ITC TRANSLATIONS USA INC 900 EAST INDIANTOWN ROAD STE 302 JUNIPER FL 33477 TRANSLATION SERVICES 330320 KORN FERRY US 1900 AVENUE OF THE STARS SUITE 2600 LOS ANGELES CA 90067 PROFESSIONAL SERVICES 255013 34 4902500 14479623 19382123 LICENSE FEES 900099 10357110 10357110 PERMISSION FEES 900099 9122863 9122863 SUBSCRIPTIONS 900099 2219026 2219026 GUIDELINE DISTRIBUTION 900099 1763746 1763746 CONSULTING FEES 900099 1723127 1723127 2252162 2252162 27438034 3911937 3911937 2902940 2902940 ADVERTISING 541800 167815 167815 167815 53802849 27438034 167815 6814877 2278263 2278263 3513734 2724366 759008 30360 16101343 14591534 1038520 471289 1055789 931590 97237 26962 3358237 2963192 309280 85765 1261256 1112888 116157 32211 516134 298170 217964 79750 17500 62250 1173038 888780 284258 168453 133497 34956 252572 46115 206426 31 1018455 405203 613252 1950155 1950155 1573664 1363009 205000 5655 2795356 2795356 402818 402818 204860 303 204557 CATERING 529311 425872 103439 HONORARIA 379405 379405 OTHER 351691 145950 204120 1621 RECRUITING EXPENSES 244354 244354 703397 609462 93440 495 39912035 32110455 7147191 654389 25536329 5401460 12530131 25805800 4661852 7494359 1480797 1735443 295880 363822 797065 1288578 3964371 2781991 1443688 1182380 72927716 97520342 13705106 12108789 133378564 152900973 3107967 2759255 21024013 21541988 14621159 13001575 38753139 37302818 X 89267100 111702981 5358325 3895174 94625425 115598155 133378564 152900973 13890814 7081916 0 X X 0 1 X 1 0 X 17231822 20946288 19295605 20368490 19382123 97224328 17231822 20946288 19295605 20368490 19382123 97224328 5863193 91361135 2187970 2455722 3140006 5593743 6814877 20192318 173053 145876 174063 101795 87229 682016 19536519 21973829 23520158 25922116 27438034 118390656 236489318 0.38630 0.42100 X SCHEDULE A - PART II SECTION B LINE 10 OTHER INCOME INCLUDES THE FOLLOWING ITEMS: LICENSE FEE REVENUE FOR LICENSING OF NCCN PRODUCTS $10,357,110 PERMISSION FEES 9,122,863 CONSULTING REVENUE 1,723,127 GUIDELINE DISTRIBUTION 1,763,746 SUBSCRIPTION REVENUE FROM THE NCCN COMPENDIA, CHEMOTHERAPY ORDER TEMPLATES AND FLASH UDPATES 2,219,026 TUITION FEES FOR NCCN ACADEMY 590,005 TRENDS SURVEY FEES FOR NCCN TRENDS REPORTS 520,442 EXHIBIT FEES FOR EXHIBITING AT NCCN EDUCATIONAL PROGRAMS 616,775 REGISTRATION FEES FOR NCCN EDUCATIONAL PROGRAMS 412,940 FELLOWSHIP GRANTS 112,000 TOTAL $27,438,034 RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 31991 31991 32078464 32110455 1000000 250000 0 0 1000000 1000000 1000000 1000000 4000000 6000000 8037 12999 16163 31991 69190 250000 250000 250000 250000 1000000 1500000 SCHEDULE C PART II-A, LINE 1 LOBBYING EXPENDITURES ON PART II-A, LINE 1 OF $31,991 INCLUDE STAFF TIME ASSOCIATED WITH LOBBYING ACTIVITIES INCLUDING BUT NOT LIMITED TO: THE REDUCING HEREDITARY CANCER ACT, THE INCREASING ACCESS TO LUNG CANCER SCREENING ACT, THE CANCER DRUG PARITY ACT, THE PSA SCREENING FOR HIM ACT, THE DIVERSE TRIALS ACT, ISSUES OF SURVIVORSHIP CARE AND RISK REDUCING INTERVENTIONS, ISSUES PERTAINING TO DRUG SHORTAGES, AS WELL AS, MEETINGS WITH VARIOUS MEMBERS OF CONGRESS AND FEDERAL AGENCIES. AT THE STATE LEVEL, LOBBYING ACTIVITIES WERE FOCUSED AROUND THE PASSAGE OF COMPREHENSIVE BIOMARKER COVERAGE LEGISLATION IN PENNSYLVANIA. 1199927 497584 702343 2764444 2284407 480037 1182380 RIGHT OF USE ASSETS - OPERATING LEASES 12108789 12108789 LEASE LIAB. - OPERATING LEASES 1679281 LEASE LIAB. - OPER. LEASE - (LT) 11322294 13001575 60884765 7081916 7081916 53802849 0 53802849 39912035 0 39912035 0 39912035 EUROPE 0 0 PROGRAM SERVICES EDUCATIONAL PROGRAM 95493 SUB-SAHARAN AFRICA 0 0 PROGRAM SERVICES CLINICAL PRACTICE GUIDELINES 88028 EAST ASIA & THE PACIFIC 0 0 PROGRAM SERVICES CLINICAL PRACTICE GUIDELINES 32655 MIDDLE EAST/NORTH AFRICA 0 0 PROGRAM SERVICES CLINICAL PRACTICE GUIDELINES 3638 0 0 0 0 0 0 219814 0 219814 0 0 0 0 0 0 SCHEDULE F - PART I LINE 3(F) THE METHOD USED TO ACCOUNT FOR THE ORGANIZATION'S EXPENDITURES IS THE ACCRUAL BASIS OF ACCOUNTING. THIS IS THE SAME METHOD USED IN THE ORGANIZATION'S FINANCIAL STATEMENTS. 1 ALLEGHENY SINGER RESEARCH INST 320 NORTH AVENUE PITTSBURG PA 15202 251320493 501(C)(3) 6000 0 RESEARCH CITY OF HOPE COMP CANCER CTR 1500 E DUARTE RD DUARTE CA 91010 951683875 501(C)(3) 92451 0 RESEARCH DANA FARBER CANCER INSTITUTE 450 BROOKLINE AVENUE BP320 BOSTON MA 02215 043320640 501(C)(3) 126942 0 RESEARCH FOX CHASE CANCER CENTER 333 COTTMAN AVENUE PHILADELPHIA PA 19111 232003072 501(C)(3) 136416 0 RESEARCH FRED HUTCHINSON CANCER RES CTR 1100 FAIRVIEW AVE N SEATTLE WA 98109 237156071 501(C)(3) 105698 0 RESEARCH HEALTH RESEARCH INC ELM AND CARLTON STREETS BUFFALO NY 14263 141402155 501(C)(3) 126350 0 RESEARCH INSTITUTE FOR CANCER RESEARCH 604 COTTMAN AVENUE CHELTENHAM PA 19012 236296135 501(C)(3) 171500 0 RESEARCH JOHNS HOPKINS UNIVERSITY 733 N BROADWAY SUITE 117 BALTIMORE MD 21205 520595110 501(C)(3) 14392 0 RESEARCH MASS GENERAL HOSPITAL 101 HUNTINGTON AVENUE SUITE 210 BOSTON MA 02199 042697983 501(C)(3) 273457 0 RESEARCH MAYO CLINIC 200 FIRST STREET SW ROCHESTER MN 55905 416011702 501(C)(3) 205306 0 RESEARCH NEW ENGLAND CANCER SPECIALISTS 100 CAMPUS DRIVE SCARBOROUGH ME 04074 221487173 501(C)(3) 28784 0 RESEARCH NORTHWESTERN UNIVERSITY HEALTH SYSTEM 750 N LAKE SHORE DRIVE 7TH FLOOR CHICAGO IL 60611 362167817 501(C)(3) 37308 0 RESEARCH ROSWELL PARK COMPREHENSIVE CANCER CENTER ELM CARLTON STREETS BUFFALO NY 14263 161552370 501(C)(3) 141667 0 RESEARCH STANFORD UNIVERSITY PO BOX 44253 SAN FRANCISCO CA 941444253 941156365 501(C)(3) 28784 0 RESEARCH REGENTS OF UNIV OF CO DENVER 1800 GRANT ST 800 DENVER CO 80203 846000555 501(C)(3) 74988 0 RESEARCH THE TRUSTEES OF THE U OF PENN 801 SPRUCE ST PHILADELPHIA PA 19107 231352685 501(C)(3) 199858 0 RESEARCH UNIVERSITY HOSP CLEVELAND MC 11100E EUCLID AVENUE CLEVELAND OH 44106 341018992 501(C)(3) 68423 0 RESEARCH THE UNIVERSITY OF TEXAS 1515 HOLCOMBE AVENUE UNIT 176 HOUSTON TX 77030 746001118 501(C)(3) 125222 0 RESEARCH UNIV OF ALABAMA AT BIRMINGHAM 1720 UNIVERSITY BLVD BIRMINGHAM AL 35294 636005396 501(C)(3) 43933 0 RESEARCH UNIVERSITY OF MICHIGAN 3003 S STATE STREET ROOM 2044 ANN ARBOR MI 48104 386006309 501(C)(3) 70000 0 RESEARCH UNIVERSITY OF WASHINGTON 825 EASTLAKE AVENUE SEATTLE WA 98109 916001537 501(C)(3) 40618 0 RESEARCH YALE UNIVERSITY 100 CHURCH STREET SOUTH SUITE A160 NEW HAVEN CT 06520 060646973 501(C)(3) 50435 0 RESEARCH UT SOUTHWESTERN MEDICAL CENTER 5323 HARRY HINES BLVD DALLAS TX 75390 756002868 501(C)(3) 91807 0 RESEARCH 28 PART I, LINE 2: NATIONAL COMPREHENSIVE CANCER NETWORK (NCCN) ENTERS INTO RESEARCH GRANT AGREEMENTS WITH INSTITUTIONS TO CONDUCT RESEARCH FOR INDIVIDUAL STUDY PROJECTS APPROVED BY NCCN'S SCIENTIFIC REVIEW COMMITTEES. THE SCOPE AND NATURE OF STUDIES TO BE PERFORMED BY GRANT RECIPIENTS ARE IN ACCORDANCE WITH THE APPROVED PROTOCOLS DEVELOPED BY THE PRINCIPAL INVESTIGATORS AND CONSISTENT WITH THE PROPOSALS SUBMITTED TO AND APPROVED BY THE NCCN SCIENTIFIC REVIEW COMMITTEES. PRINCIPAL INVESTIGATORS OR THEIR INSTITUTIONS MUST ATTEST THAT THEY WILL ABIDE BY THE TERMS OF NCCN RESEARCH AGREEMENTS AND THAT THE PRINCIPAL INVESTIGATORS HAVE NOT BEEN DEBARRED OR DISQUALIFIED UNDER ANY RELEVANT STATUTES. IF AN INSTITUTION DOES NOT COMMENCE A STUDY WITHIN THE REQUIRED TIMELINE, NCCN MAY REQUEST THE INVESTIGATOR SUBMIT A CORRECTIVE ACTION PLAN FOR NCCN'S APPROVAL OR TERMINATE THE STUDY. DURING THE TERM OF THE GRANT, INSTITUTIONS REPORT TO NCCN ON AT LEAST A QUARTERLY BASIS. REPORTS INCLUDE AN UPDATE ON THE STATUS AND PROGRESS OF THE FUNDED STUDIES INCLUDING AN ASSESSMENT OF TOTAL ENROLLMENT OR STUDY PROGRESS, ELIGIBILITY, AND ACCRUAL OF PATIENTS AS APPLICABLE. IN CONSIDERATION FOR PERFORMANCE OF THE STUDY, NCCN DISTRIBUTES GRANT MONIES TO INSTITUTIONS WHEN CERTAIN BENCHMARK MILESTONES ARE MET AND FINAL PAYMENT IS DISBURSED UPON RECEIPT OF THE FINAL BENCHMARK MILESTONE IN THE FORM OF FINAL REPORTS AND / OR MANUSCRIPTS. INSTITUTIONS THAT DO NOT ENROLL OR COMPLETE THEIR STUDIES FULLY ARE REQUIRED TO RECONCILE STUDY EXPENSES AT TERMINATION OR COMPLETION AND RETURN UNUSED FUNDS TO NCCN WHICH ARE IN TURN RETURNED TO THE GRANTOR. X X X X X X 0 0 0 0 0 0 0 0 0 ROBERT W CARLSON MD CHIEF EXECUTIVE OFFICER - FORMER 837016 0 303928 0 0 0 33000 0 28847 0 1202791 0 0 0 GARY WEYHMULLER CHIEF OPERATING OFFICER 550455 0 53000 0 0 0 33000 0 31470 0 667925 0 0 0 WUI-JIN KOH MD CHIEF MEDICAL OFFICER 538772 0 53141 0 0 0 33000 0 14978 0 639891 0 0 0 CRYSTAL DENLINGER CHIEF EXECUTIVE OFFICER 395084 0 83920 0 0 0 33000 0 14978 0 526982 0 0 0 KRISTINA M GREGORY SENIOR VP, CLINICAL INFORMATION P 323392 0 29665 0 0 0 32580 0 14978 0 400615 0 0 0 EILEEN BOSCIA CHIEF FINANCIAL OFFICER 314361 0 31000 0 0 0 31597 0 15868 0 392826 0 0 0 BETH GAFFNEY VP - US & GLOBAL BUSINESS 245436 0 25000 0 0 0 25601 0 44428 0 340465 0 0 0 JENNIFER TREDWELL SENIOR VP, MARKETING & COMMUNICATION 206964 0 21210 0 0 0 21618 0 38428 0 288220 0 0 0 JOSEPH JUNOD SENIOR DIRECTOR, IT 184675 0 9460 0 0 0 12635 0 38428 0 245198 0 0 0 DONNA POWELL MANAGER, RADIATION THERAPY & IMAGING 181240 0 8520 0 0 0 12279 0 30832 0 232871 0 0 0 EVELYN HANDEL SENIOR DIRECTOR, DRUGS & BIOLOGICS P 189897 0 5535 0 0 0 12570 0 15237 0 223239 0 0 0 FORM 990, PART I, LINE 6, VOLUNTEERS: NCCN HAD 1,912 VOLUNTEERS COMMIT APPROXIMATELY 47,021 VOLUNTEER HOURS AS PANEL MEMBERS UPDATING EACH OF THE NCCN GUIDELINES FOR CANCER TREATMENT. FORM 990, PART VI, SECTION B, LINE 11B NCCN PROVIDES A DRAFT COPY OF THE FORM 990 TO THE FINANCE COMMITTEE OF THE BOARD OF DIRECTORS FOR ITS REVIEW AND APPROVAL PRIOR TO FILING THE RETURN. FORM 990, PART VI, SECTION B, LINE 12C NCCN REQUIRES OFFICERS, DIRECTORS, AND KEY EMPLOYEES TO ANNUALLY COMPLETE A CONFLICT OF INTEREST QUESTIONNAIRE. THIS QUESTIONNAIRE SHALL BE UPDATED AS NECESSARY TO REFLECT CHANGES DURING THE COURSE OF THE YEAR. COMPLETED QUESTIONNAIRES SHALL BE AVAILABLE FOR INSPECTION BY ANY BOARD MEMBER AND MAY BE REVIEWED BY NCCN'S LEGAL COUNSEL. SENIOR NCCN STAFF REVIEW THE CONFLICT OF INTEREST FORMS ANNUALLY, PROVIDE A REPORT TO THE EXECUTIVE COMMITTEE AND TAKE CORRECTIVE ACTION IF NEEDED. FORM 990, PART VI, SECTION B, LINE 15 THE COMPENSATION OF NCCN'S CHIEF EXECUTIVE OFFICER (CEO) IS REVIEWED PERIODICALLY BY AN INDEPENDENT ORGANIZATION ENGAGED BY THE CHAIRMAN OF NCCN'S BOARD OF DIRECTORS TO CONDUCT A SALARY COMPARABILITY STUDY AND SURVEY. A SALARY COMPARABILITY STUDY AND SURVEY WAS COMPLETED DURING 2022. THE INFORMATION FROM THE SURVEY CONDUCTED BY THE INDEPENDENT ORGANIZATION IS FORWARDED TO NCCN'S EXECUTIVE COMMITTEE OF THE BOARD OF DIRECTORS FOR THEIR REVIEW. EACH YEAR, THE EXECUTIVE COMMITTEE OF NCCN'S BOARD OF DIRECTORS RECEIVES INFORMATION REGARDING THE CEO'S PAST SALARY HISTORY AS WELL AS THE CEO'S ACCOMPLISHMENTS. NCCN'S EXECUTIVE COMMITTEE SCHEDULES A CONFERENCE CALL TO REVIEW THIS INFORMATION AND TO DISCUSS RECOMMENDATIONS FOR THE CEO'S SALARY AND BONUS FOR THE UPCOMING YEAR. FORM 990, PART VI, SECTION B, LINE 15B THE COMPENSATION OF NCCN'S CHIEF OPERATING OFFICER (COO), CHIEF MEDICAL OFFICER, CHIEF SCIENTIFIC OFFICER, AND CHIEF FINANCIAL OFFICER (CFO) IS REVIEWED PERIODICALLY BY AN INDEPENDENT ORGANIZATION ENGAGED BY THE CEO OF NCCN. A SALARY COMPARABILITY STUDY AND SURVEY WAS COMPLETED DURING 2022. THE ORGANIZATION CONDUCTS A SALARY COMPARABILITY STUDY AND SURVEY FOR COMPARABLE POSITIONS IN SIMILAR ORGANIZATIONS. THE CEO REVIEWS THE SALARY STUDY AND SURVEY TO DETERMINE THE COMPENSATION FOR THE ABOVE KEY EMPLOYEES OF NCCN. FORM 990, PART VI, SECTION C, LINE 19 NCCN MAKES ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC UPON REQUEST. FORM 990, PART XII, LINE 2C: THE FINANCE COMMITTEE ASSUMES RESPONSIBILITY FOR THE OVERSIGHT OF THE AUDIT AND SELECTION OF AN INDEPENDENT ACCOUNTANT. NCCN FOUNDATION 3025 CHEMICAL ROAD SUITE 100 PLYMOUTH MEETING PA 19462 271536314 FOUNDATION DE 501(C)(3) LINE 7 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 1 1 0 0 0 NCCN FOUNDATION L 1612577 FMV NCCN FOUNDATION O 1179851 FMV NCCN FOUNDATION P 201991 FMW PART V LINE 2, COLUMN C TRAVEL AND MEETINGS $72,691 MARKETING AND PUBLIC RELATIONS 70,120 PROFESSIONAL FEES 33,825 OFFICE EXPENSE 11,089 OTHER EXPENSES 13,736 SUPPLIES AND PRINTING 467 TELEPHONE 63 TOTAL PART V - LINE 2(3) $201,991